A great deal of life science funding was awarded to Duke University on June 14th, 2013 when the NIH gave researchers $13.8 million to study the induction of protective B-cell responses to HIV-1. The study’s project leader, Barton Haynes, is Director of the Human Vaccine Institute in the Department of Medicine. According to the Duke University website, Dr. Haynes’s laboratory is interested in researching host innate and adaptive immune responses to the human immunodeficiency virus (HIV), tuberculosis (TB), and influenza so that they can understand better ways to make preventive vaccines against these three infectious diseases. The NIH RePORTER goes into more detail about the project receiving $13.8 million in NIH life science research funding:
“In the B Cell Focus our overall goals are to 1) design Env immunogens that will elicit both difficult-to-induce broad neutralizing antibodies, and also 2) induce easier-to-induce protective antibodies. The goal is to induce both types of antibodies in most vaccinated subjects. Specific aims include: Aim 1. To define the nature of protective systemic and mucosal immunity in vaccinated subjects. Aim 2. To design novel gp120/gp140 immunogens that induces protective mucosal and systemic antibody responses to HlV-1. Aim 3. To define host factors that may limit the induction of broadly neutralizing antibodies. Aim 4. To design immunogens that target unmutated ancestor and intermediate antibodies of the maturation pathways of protective anti-HlV-1 Env antibodies. Aim 5. To use structural biological information and technology to design immunogens.”
Duke BioResearch Product Faire™ Event
Lab suppliers interested in learning more about Duke University life science research funding at Duke University may also be interested to know that Duke is a very well-funded market. Duke University received $355.6 million in life science funding from the NIH in 2012. For a full list of life science departments receiving NIH funding, please visit the NIH website. In addition to receiving a great deal of life science research funding from the NIH, Duke University also received $46 million from the NSF in 2012.
In light of this most recent NIH grant and other recent NIH and NSF life science funding statistics, lab suppliers may want to consider exhibiting at Duke University life science marketing events. If you are a lab supplier interested in networking with researchers and lab managers at Duke University, Biotechnology Calendar, Inc. invites you to attend our annual Duke BioResearch Product Faire™ Event. Last year, the Duke BioResearch Product Faire™ Event attracted 228 attendees. Of the attendees, 72 were purchasing agents, professors and post docs, and 35 were lab managers. The visitors came from 21 research buildings and 41 departments around campus.
Biotechnology Calendar, Inc. is a full-service science research marketing and events-planning company that has been organizing life science marketing events at top research universities across the country for 20 years. If you are interested in learning about the Duke University life sciences market or exhibiting at life science marketing events closer to home, we encourage you to view our 2013 calendar of events. For more funding statistics on Duke University, or to learn more about the Duke BioResearch Product Faire™ Event, click on the button below.